Oxford Immunotec Global PLC (OXFD.OQ)
OXFD.OQ on NASDAQ Stock Exchange Global Market
12.94USD
4:00pm EDT
12.94USD
4:00pm EDT
Change (% chg)
$-0.22 (-1.67%)
$-0.22 (-1.67%)
Prev Close
$13.16
$13.16
Open
$13.14
$13.14
Day's High
$13.25
$13.25
Day's Low
$12.88
$12.88
Volume
21,020
21,020
Avg. Vol
55,649
55,649
52-wk High
$19.50
$19.50
52-wk Low
$10.26
$10.26
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 25.03 | 1.182 |
| Sep '17 | 30.43 | -0.698 | |
| Jun '17 | 26.12 | -0.735 | |
| Mar '17 | 21.50 | -0.358 | |
| FY 2016 | Dec '16 | 23.70 | -0.217 |
| Sep '16 | 26.11 | -0.179 | |
| Jun '16 | 19.15 | -0.288 | |
| Mar '16 | 17.11 | -0.316 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 5 | 28.49 | 29.06 | 28.00 | 29.65 |
| Quarter Ending Sep-18 | 5 | 33.43 | 33.67 | 33.00 | 34.82 |
| Year Ending Dec-18 | 5 | 112.32 | 112.60 | 112.00 | 121.28 |
| Year Ending Dec-19 | 5 | 127.36 | 129.26 | 125.54 | 139.30 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 5 | -0.26 | -0.20 | -0.33 | -0.19 |
| Quarter Ending Sep-18 | 5 | -0.10 | -0.07 | -0.14 | -0.06 |
| Year Ending Dec-18 | 5 | -1.01 | -0.94 | -1.18 | -0.67 |
| Year Ending Dec-19 | 5 | -0.79 | -0.60 | -1.07 | -0.33 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 33.95 | 33.50 | |
| P/E High - Last 5 Yrs. | -- | 76.44 | 46.07 | |
| P/E Low - Last 5 Yrs. | -- | 21.28 | 24.95 | |
| Beta | -0.31 | 0.86 | 0.80 | |
| Price to Sales (TTM) | 3.30 | 19.44 | 7.25 | |
| Price to Book (MRQ) | 3.85 | 4.66 | 5.09 | |
| Price to Tangible Book (MRQ) | 4.49 | 6.43 | 6.62 | |
| Price to Cash Flow (TTM) | -- | 22.72 | 25.50 | |
| % Owned Institutions | 94.81 | 28.34 | 2.24 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.71 | 1.53 | |
| Dividend Yield - 5 Year Avg | -- | 0.69 | 0.75 | |
| Dividend 5 Year Growth Rate | -- | 5.75 | 3.92 | |
| Payout Ratio(TTM) | -- | 15.52 | 20.54 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 5.57 | 18.20 | 8.68 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 19.75 | 9.51 | 11.19 | |
| Sales - 5 Yr. Growth Rate | 37.88 | 4.50 | 8.22 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 645.29 | 54.74 | 22.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 39.02 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 5.76 | 10.28 | |
| Capital Spending - 5 Yr. Growth Rate | 27.68 | 11.42 | 10.41 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 4.92 | 1.82 | 2.53 |
| Current Ratio (MRQ) | 5.37 | 2.34 | 3.61 |
| LT Debt to Equity (MRQ) | 34.13 | 33.29 | 11.39 |
| Total Debt to Equity (MRQ) | 34.23 | 43.68 | 14.02 |
| Interest Coverage (TTM) | -- | 57.13 | 39.28 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 54.67 | 47.99 | 54.05 | |
| Gross Margin - 5 Yr. Avg. | 53.46 | 55.86 | 52.18 | |
| EBITD Margin (TTM) | -20.39 | -- | -- | |
| EBITD - 5 Yr. Avg | -26.59 | 14.56 | 15.90 | |
| Operating Margin (TTM) | -25.31 | -19.05 | 4.09 | |
| Operating Margin - 5 Yr. Avg. | -30.99 | 6.79 | 11.23 | |
| Pre-Tax Margin (TTM) | -30.32 | -15.27 | 4.81 | |
| Pre-Tax Margin - 5 Yr. Avg. | -33.01 | 6.10 | 11.54 | |
| Net Profit Margin (TTM) | -11.14 | -17.75 | 1.42 | |
| Net Profit Margin - 5 Yr. Avg. | -26.20 | 3.71 | 7.87 | |
| Effective Tax Rate (TTM) | -- | 18.98 | 30.96 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 21.39 | 24.26 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 225,558 | 14,559,125 | 813,295,447 | |
| Net Income/Employee (TTM) | -25,131 | 1,143,650 | 95,590,786 | |
| Receivable Turnover (TTM) | 6.82 | 5.12 | 5.56 | |
| Inventory Turnover (TTM) | 5.32 | 4.38 | 3.44 | |
| Asset Turnover (TTM) | 0.77 | 0.77 | 0.89 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -8.56 | 0.81 | 10.51 | |
| Return on Assets - 5 Yr. Avg. | -18.37 | 5.45 | 11.54 | |
| Return on Investment (TTM) | -10.11 | 9.95 | 13.17 | |
| Return on Investment - 5 Yr. Avg. | -21.57 | 6.96 | 14.94 | |
| Return on Equity (TTM) | -14.30 | 14.72 | 14.98 | |
| Return on Equity - 5 Yr. Avg. | -24.81 | 8.83 | 16.23 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 19.75 | 27.70 | 37.88 |
| EPS (TTM) % | 51.65 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Oxford Immunotec Global PLC
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Oxford Immunotec Q4 Earnings Per Share $0.33
- BRIEF-James Flynn Reports 5.1 Pct Passive Stake In Oxford Immunotec Global Plc As Of Jan 22
- BRIEF-Oxford Immunotec Announces Preliminary Revenue For Q4
- Qiagen to pay Oxford Immunotec $27.5 million to settle patent case
- BRIEF-Oxford Immunotec And Qiagen Reached A Settlement In Lawsuit
Institutional Holders
| % Shares Owned: | 94.53% |
| # of Holders: | 107 |
| Total Shares Held: | 24,457,361 |
| 3 Mo. Net Change: | 31,166 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 4 |
| # Reduced Positions: | 4 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.